July 27, 2018: Boehringer Ingelheim receives its Fourth ETP contract for $900,000 — to support a plant expansion

Contact: Alfonso Perez
Quality Systems Manager
Boehringer Ingelheim
6701 Kaiser Drive
Fremont, CA 94555

Boehringer Ingelheim is investing $217 million to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and highly-skilled positions to the City of Fremont. The site was recently awarded $25.5 million in two separate tax credits from the state and another $900,000 in ETP funds, making them the largest awards to a pharmaceutical company. This significant expansion will enable the company to increase its manufacturing capacity by one-third.

Under this new proposal, BIFI will deliver more customized, advanced bio-tech manufacturing skills training using all three available ETP methodologies including class/lab, CBT, and Productive Lab. The proposed training plan is designed to expand trainee skills enabling them to adapt to changing business requirements; improve product quality; and gain transferable skills in advanced biotechnologies, pharmaceutical equipment, and processes. Training for frontline manufacturing workers under this proposal is different from previous ETP Agreements because it will focus primarily on new product manufacturing technologies and procedures.